Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
grade F 1.27 0.79% 0.01
MYO closed up 0.79 percent on Friday, March 22, 2019, on 68 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical MYO trend table...

Date Alert Name Type % Chg
Mar 22 20 DMA Support Bullish 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 21 Crossed Above 20 DMA Bullish 0.79%
Mar 21 Bollinger Band Squeeze Range Contraction 0.79%
Mar 20 Fell Below 20 DMA Bearish 1.60%
Mar 20 Bollinger Band Squeeze Range Contraction 1.60%
Mar 19 20 DMA Support Bullish 0.00%
Mar 19 Bollinger Band Squeeze Range Contraction 0.00%

Older signals for MYO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
Medical Specialties Organ Systems Multiple Sclerosis Neurological Disorders Amyotrophic Lateral Sclerosis Podiatry Skeletal System Stroke Muscular System Neurotrauma Orthopedics
Is MYO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.3
52 Week Low 1.15
Average Volume 98,005
200-Day Moving Average 1.9424
50-Day Moving Average 1.4262
20-Day Moving Average 1.2545
10-Day Moving Average 1.269
Average True Range 0.0919
ADX 14.38
+DI 20.9304
-DI 15.2998
Chandelier Exit (Long, 3 ATRs ) 1.3843
Chandelier Exit (Short, 3 ATRs ) 1.4257
Upper Bollinger Band 1.3169
Lower Bollinger Band 1.1921
Percent B (%b) 0.62
BandWidth 9.948187
MACD Line -0.0376
MACD Signal Line -0.0511
MACD Histogram 0.0135
Fundamentals Value
Market Cap 7.73 Million
Num Shares 6.09 Million
EPS -8.54
Price-to-Earnings (P/E) Ratio -0.15
Price-to-Sales 14.12
Price-to-Book 4.12
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.34
Resistance 3 (R3) 1.33 1.31 1.32
Resistance 2 (R2) 1.31 1.29 1.31 1.32
Resistance 1 (R1) 1.29 1.28 1.30 1.29 1.32
Pivot Point 1.26 1.26 1.27 1.27 1.26
Support 1 (S1) 1.25 1.25 1.26 1.25 1.22
Support 2 (S2) 1.22 1.24 1.22 1.22
Support 3 (S3) 1.20 1.22 1.22
Support 4 (S4) 1.20